AMDS Hybrid Prosthesis
Tracked across 1 events · 6 articles · First seen Jun 29, 2026 · Last active Jun 29, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: The AMDS Hybrid Prosthesis received PMA approval, allowing for broader adoption and use in treating acute DeBakey Type I aortic dissections. It has shown significant reductions in mortality and major adverse events.
Jun 29, 2026 · 6 articles
ERGEN INTELLIGENCE
Track AMDS Hybrid Prosthesis live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard